Little interviews biologist Masayo Takahashi. Among other things, Takahashi talks about the first ever safety study of re-injecting a patient's own reprogrammed cells called induced pluripotent stem (IPS), how treatment with IPS cells would work, and what the future holds for IPS cells.
© 2001-2024 Fundación Dialnet · Todos los derechos reservados